Seelos Therapeutics, Inc.
SEELQ
$0.0005
$0.000.00%
OTC PK
| 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 294.00K | 524.00K | 3.00M | 2.58M | 5.84M |
| Total Receivables | 188.00K | 968.00K | 763.00K | 221.00K | 431.00K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 1.71M | 1.94M | 1.57M | 3.33M | 5.42M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 147.00K | 115.00K | 77.00K | 53.00K | 151.00K |
| Total Current Assets | 2.33M | 3.55M | 5.40M | 6.19M | 11.85M |
|
|
|||||
| Total Current Assets | 2.33M | 3.55M | 5.40M | 6.19M | 11.85M |
| Net Property, Plant & Equipment | 47.00K | 62.00K | 15.00K | 30.00K | 44.00K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 2.38M | 3.61M | 5.42M | 6.22M | 11.89M |
|
|
|||||
| Total Accounts Payable | 15.69M | 15.27M | 16.40M | 9.32M | 6.44M |
| Total Accrued Expenses | 4.36M | 4.52M | 2.52M | 6.34M | 5.59M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 10.16M | 13.14M | 14.23M | 15.60M | 12.39M |
| Total Finance Division Other Current Liabilities | 313.00K | 3.79M | 5.78M | 4.06M | 31.70M |
| Total Other Current Liabilities | 313.00K | 3.79M | 5.78M | 4.06M | 31.70M |
| Total Current Liabilities | 30.51M | 36.72M | 38.93M | 35.33M | 56.11M |
|
|
|||||
| Total Current Liabilities | 30.51M | 36.72M | 38.93M | 35.33M | 56.11M |
| Long-Term Debt | -- | -- | -- | 1.30M | 2.96M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 30.51M | 36.72M | 38.93M | 36.63M | 59.07M |
|
|
|||||
| Common Stock & APIC | 225.45M | 222.19M | 219.12M | 216.76M | 210.49M |
| Retained Earnings | -253.58M | -255.29M | -252.63M | -247.17M | -257.67M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -28.13M | -33.10M | -33.51M | -30.41M | -47.18M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -28.13M | -33.10M | -33.51M | -30.41M | -47.18M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -28.13M | -33.10M | -33.51M | -30.41M | -47.18M |
|
|
|||||